BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26107253)

  • 21. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
    Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
    J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk of depression in non-depressed HIV infected men with sleep disturbance: Prospective findings from the Multicenter AIDS Cohort Study.
    Irwin MR; Archer G; Olmstead R; Brown TT; Teplin LA; Patel SR; Abraham AG; Breen EC
    EBioMedicine; 2018 Oct; 36():454-460. PubMed ID: 30249545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroepidemiology of HIV infection.
    Dal Pan GJ; McArthur JC
    Neurol Clin; 1996 May; 14(2):359-82. PubMed ID: 8827177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women and AIDS in Zimbabwe: the making of an epidemic.
    Bassett MT; Mhloyi M
    Int J Health Serv; 1991; 21(1):143-56. PubMed ID: 2004868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurologic disorders associated with AIDS retroviral infection.
    Elder GA; Sever JL
    Rev Infect Dis; 1988; 10(2):286-302. PubMed ID: 2836938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
    J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke and HIV-associated neurological complications: A retrospective nationwide study.
    Patel UK; Malik P; Li Y; Habib A; Shah S; Lunagariya A; Jani V; Dhamoon MS
    J Med Virol; 2021 Aug; 93(8):4915-4929. PubMed ID: 33837961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of mortality among adult people living with HIV/AIDS on antiretroviral therapy at Suhul Hospital, Tigrai, Northern Ethiopia: a retrospective follow-up study.
    Misgina KH; Weldu MG; Gebremariam TH; Weledehaweria NB; Alema HB; Gebregiorgis YS; Tilahun YG
    J Health Popul Nutr; 2019 Nov; 38(1):37. PubMed ID: 31783924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurologic complications of pediatric human immunodeficiency virus: implications for clinical practice and management challenges in the African setting.
    Donald KA; Hoare J; Eley B; Wilmshurst JM
    Semin Pediatr Neurol; 2014 Mar; 21(1):3-11. PubMed ID: 24655398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women and HIV. Epidemiology and global overview.
    Fowler MG; Melnick SL; Mathieson BJ
    Obstet Gynecol Clin North Am; 1997 Dec; 24(4):705-29. PubMed ID: 9430163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What explains gender inequalities in HIV/AIDS prevalence in sub-Saharan Africa? Evidence from the demographic and health surveys.
    Sia D; Onadja Y; Hajizadeh M; Heymann SJ; Brewer TF; Nandi A
    BMC Public Health; 2016 Nov; 16(1):1136. PubMed ID: 27809824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of human immunodeficiency virus type 1-related neurologic disease in a cohort of intravenous drug users.
    Marder K; Liu X; Stern Y; Malouf R; Dooneief G; Bell K; Todak G; Joseph M; Sorrell S; el Sadr W
    Arch Neurol; 1995 Dec; 52(12):1174-82. PubMed ID: 7492292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV infection among men who have sex with men in Israel: a 35-year epidemiological and clinical overview, 1981-2015.
    Chemtob D; Mor Z; Harel N; Averick N
    BMC Public Health; 2019 Jun; 19(1):747. PubMed ID: 31196014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender and survival after AIDS in Rio de Janeiro, Brazil.
    Santoro-Lopes G; Harrison LH; Moulton LH; Lima LA; de Pinho AM; Hofer C; Schechter M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):403-7. PubMed ID: 9833750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
    Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
    PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends of Cause of Death among Human Immunodeficiency Virus Patients and the Impact of Low CD4 Counts on Diagnosis to Death: a Retrospective Cohort Study.
    Kim Y; Kim SW; Chang HH; Kwon KT; Bae S; Hwang S
    J Korean Med Sci; 2020 Oct; 35(41):e355. PubMed ID: 33107229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of human immunodeficiency virus infection and associated neurologic illness.
    Lanska DJ
    Semin Neurol; 1999; 19(2):105-11. PubMed ID: 10718532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS).
    Farinpour R; Miller EN; Satz P; Selnes OA; Cohen BA; Becker JT; Skolasky RL; Visscher BR
    J Clin Exp Neuropsychol; 2003 Aug; 25(5):654-70. PubMed ID: 12815503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pearls: neurologic complications of HIV/AIDS.
    Berger JR
    Semin Neurol; 2010 Feb; 30(1):66-70. PubMed ID: 20127584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurologic complications of human immunodeficiency virus-type 1 infection.
    Kim HJ; Kim S; Lee KB; Lee KW; Oh MD; Choe KW
    J Korean Med Sci; 2003 Apr; 18(2):149-57. PubMed ID: 12692408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.